REMUREL 40mg / ml injection solution in pre-filled syringe medication leaflet

L03AX13 glatiramer acetate • Antineoplastic and immunomodulating agents | Immunostimulants | Other immunostimulants

Glatiramer acetate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by modulating the immune response, reducing inflammation, and preventing damage to myelin, the protective layer of nerves.

The medication is administered via subcutaneous injection, usually daily or several times a week, depending on the dosage. Glatiramer acetate has shown efficacy in reducing relapse frequency and slowing disease progression.

Common side effects include injection site reactions, flushing, and palpitations. It is important for patients to be properly trained in injection administration and monitored for potential side effects.

Glatiramer acetate is a well-established therapeutic option for patients with multiple sclerosis, helping to improve their quality of life.

General data about REMUREL 40mg / ml

Substance: glatiramer acetate

Date of last drug list: 01-06-2025

Commercial code: W68201002

Concentration: 40mg / ml

Pharmaceutical form: injection solution in pre-filled syringe

Quantity: 12

Product type: generic

Price: 2202.27 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SYNTHON HISPANIA, S.L. - SPANIA

Holder: LABORMED PHARMA S.A. - ROMANIA

Number: 10601/2018/02

Shelf life: 3 years

Concentrations available for glatiramer acetate

20mg, 20mg/ml, 40mg/ml

Compensation lists for REMUREL 40mg / ml LABORMED

NHP 4.A (C2) - Multiple sclerosis

Price

Copayment

Patient

2202.27 RON

2202.27 RON

0.00 RON